Today: 7 March 2026
Subscribe

Shan Ahmed Khan

As a journalist focused on finance and the stock market, he delivers fast, reliable, and easy-to-understand coverage of market news.

Lovable Raises $330 Million at a $6.6 Billion Valuation as Alphabet’s CapitalG and Nvidia’s NVentures Double Down on “Vibe Coding”

Lovable Raises $330 Million at a $6.6 Billion Valuation as Alphabet’s CapitalG and Nvidia’s NVentures Double Down on “Vibe Coding”

Lovable, a Stockholm-based AI software firm, raised $330 million in Series B funding at a $6.6 billion valuation, nearly quadrupling its worth in under six months. The round was led by CapitalG and Menlo Ventures’ Anthology fund, with participation from major tech investors and corporate venture arms including Nvidia, Salesforce, and Databricks.
18 December 2025
Hudson Pacific Properties (HPP) Stock Update: Riot Games Deal, Debt Paydown, Reverse Split, and What Analysts Forecast on Dec. 18, 2025

Hudson Pacific Properties (HPP) Stock Update: Riot Games Deal, Debt Paydown, Reverse Split, and What Analysts Forecast on Dec. 18, 2025

Hudson Pacific Properties shares fell sharply Thursday, trading near $10.31 after a steep drop. The company sold its Element LA office campus to Riot Games for $150 million and received an $81 million lease-termination payment, totaling $231 million. Hudson Pacific used about $206 million of the proceeds to repay mortgage debt tied to the property.
18 December 2025
··
Fermi Inc (FRMI) Stock on Dec. 18, 2025: Amazon-Tenant Claims Clash With Company Denial as Analysts Recut Targets After Project Matador Setback

Fermi Inc (FRMI) Stock on Dec. 18, 2025: Amazon-Tenant Claims Clash With Company Denial as Analysts Recut Targets After Project Matador Setback

Fermi Inc shares closed at $8.34 on Dec. 18, down 7.98%, following a volatile week after its $150 million construction funding deal for Project Matador was terminated with no funds drawn. The stock plunged 33.84% on Dec. 12 after the announcement. Business Insider reported Amazon was the withdrawn tenant, but Fermi and its CEO denied the claim to Reuters.
18 December 2025
··
Wave Life Sciences (WVE) Stock News Today (Dec. 18, 2025): Why Shares Are Sliding, New Analyst Targets, and the Next Catalysts After WVE-007 Obesity Data

Wave Life Sciences (WVE) Stock News Today (Dec. 18, 2025): Why Shares Are Sliding, New Analyst Targets, and the Next Catalysts After WVE-007 Obesity Data

Wave Life Sciences shares fell to the mid-$15 range on December 18, 2025, following a volatile period sparked by positive Phase 1 data for its obesity drug candidate WVE-007 and a large equity offering. No new announcements drove the move; trading reflected continued volatility after the early December clinical data and financing. Analysts remain bullish, but dilution and early-stage risk weigh on the stock.
18 December 2025
Crinetics Pharmaceuticals (CRNX) Stock Drops After CMO Departure Filing: Latest News, Analyst Forecasts, and What’s Next (Dec. 18, 2025)

Crinetics Pharmaceuticals (CRNX) Stock Drops After CMO Departure Filing: Latest News, Analyst Forecasts, and What’s Next (Dec. 18, 2025)

Crinetics Pharmaceuticals shares fell about 8% Thursday after a regulatory filing disclosed Chief Medical and Development Officer Dr. Dana Pizzuti will step down December 31. She will transition to a Strategic Regulatory and Development Advisor role in early 2026. The stock traded in the low-to-high $40s as investors reacted to the leadership change.
18 December 2025
·
Birkenstock (BIRK) Stock Slides on FY2026 Outlook as Tariffs and FX Bite, Despite a FY2025 Beat

Birkenstock (BIRK) Stock Slides on FY2026 Outlook as Tariffs and FX Bite, Despite a FY2025 Beat

Birkenstock shares fell 8% to $42.58 on Dec. 18 after the company posted record fiscal 2025 revenue of €2.1 billion and strong profit growth but issued cautious 2026 guidance citing tariff and currency pressures. The stock swung between $39.73 and $46.75 in heavy trading as investors reacted to margin concerns despite robust recent results.
18 December 2025
··
Edgewise Therapeutics Stock (EWTX) Today: Why Shares Fell on Dec. 18, 2025, Plus Latest News, Analyst Forecasts, and Key Clinical Catalysts

Edgewise Therapeutics Stock (EWTX) Today: Why Shares Fell on Dec. 18, 2025, Plus Latest News, Analyst Forecasts, and Key Clinical Catalysts

Edgewise Therapeutics shares fell 8.8% to $20.35 on Thursday, with no new company news released that day. The stock traded between $20.33 and $22.81 on volume of about 1.25 million shares. EWTX remains 38% below its 52-week high and 92% above its 52-week low. The company’s recent updates include a December stock option grant and a November board appointment.
18 December 2025
··
ABM Industries (NYSE:ABM) Stock Slides on Dec. 18 After Q4 Earnings: WGNSTAR Deal, 2026 Outlook, Dividend Hike and Analyst Calls

ABM Industries (NYSE:ABM) Stock Slides on Dec. 18 After Q4 Earnings: WGNSTAR Deal, 2026 Outlook, Dividend Hike and Analyst Calls

ABM Industries shares fell 10.6% Thursday to $43.13 after reporting adjusted Q4 EPS of $0.88, missing consensus, though revenue rose 5.4% to $2.295 billion, beating estimates. The company cited a $0.26 per-share hit from self-insurance adjustments and announced a $275 million acquisition. UBS downgraded the stock, citing margin and leverage concerns.
18 December 2025
···
Inspire Medical Systems (INSP) Stock Plunges on Medicare Coding Reversal: Latest News, Analyst Forecasts, and What Investors Are Watching

Inspire Medical Systems (INSP) Stock Plunges on Medicare Coding Reversal: Latest News, Analyst Forecasts, and What Investors Are Watching

Inspire Medical Systems shares fell sharply on December 18, 2025, after two Medicare contractors, CGS and Noridian, pulled CPT code 64568 for hypoglossal nerve stimulation and redirected billing to CPT 64582. The move cast doubt on a key reimbursement upgrade that had driven recent stock gains, sending INSP down in the mid-to-high teens by early afternoon.
18 December 2025
Insmed Stock (NASDAQ: INSM) Slides on Brensocatib Sinus-Trial Failure; Analysts Reset Forecasts

Insmed Stock (NASDAQ: INSM) Slides on Brensocatib Sinus-Trial Failure; Analysts Reset Forecasts

Insmed shares fell 16% Thursday after the company said its Phase 2b trial of brensocatib in chronic rhinosinusitis without nasal polyps failed to meet endpoints, prompting it to end development for that indication. The drug’s performance matched or trailed placebo on symptom scores. Insmed reported no new safety issues. The stock traded near $166.75 after hitting a low of $158.06.
18 December 2025
···
Upstart Stock News Today: UPST Jumps on Tech CU Partnership as Wall Street Weighs 2026 Outlook (Dec. 18, 2025)

Upstart Stock News Today: UPST Jumps on Tech CU Partnership as Wall Street Weighs 2026 Outlook (Dec. 18, 2025)

Upstart Holdings shares rose about 8% to near $49 on December 18 after Technology Credit Union announced it will use Upstart’s AI platform for personal and auto refinance loans. Tech CU began lending through Upstart’s network in September. Trading volume was below average despite the price jump. Analyst sentiment on the stock remains split.
18 December 2025
·
ICE Barcelona 2026: Malta’s iGaming Push, Property Appeal and the EU’s Ukraine Funding Crunch

ICE Barcelona 2026: Malta’s iGaming Push, Property Appeal and the EU’s Ukraine Funding Crunch

EU leaders met in Brussels Thursday to debate a €90 billion “reparations loan” for Ukraine, funded by profits from frozen Russian central bank assets. Belgium pressed for legal guarantees as most assets are held via Brussels-based Euroclear. In Malta, officials promoted the island’s stability and regulatory framework at a gaming industry event in Barcelona. Malta’s real estate market showed continued resilience, according to a new market analysis.
18 December 2025
BETA Technologies Stock (NYSE: BETA) Surges as BofA Raises Price Target and U.S. DOT Unveils Advanced Air Mobility Roadmap

BETA Technologies Stock (NYSE: BETA) Surges as BofA Raises Price Target and U.S. DOT Unveils Advanced Air Mobility Roadmap

BETA Technologies shares rose 6.83% to $29.88 on December 18 after Bank of America raised its price target to $37 and the U.S. Department of Transportation announced a national strategy for advanced air mobility. The stock, which debuted in November at $34 per share, touched an intraday high of $30.49. Trading volume was lighter than usual.
18 December 2025
·
Karman Holdings (KRMN) Stock: News, Forecasts, and Analyst Outlook for December 18, 2025

Karman Holdings (KRMN) Stock: News, Forecasts, and Analyst Outlook for December 18, 2025

Karman Holdings (NYSE: KRMN) rose nearly 6% to $68.93 on December 18 after an SEC filing showed Oak Thistle LLC bought 24,538 shares valued at $1.77 million in Q3. The stock traded between $67.04 and $70.88 during the session and holds a market cap near $8.6 billion. Karman supplies subsystems for space and defense programs and reports over 80 customers across 130 projects.
18 December 2025
·
Applied Digital Corporation (APLD) Stock Jumps on New Macquarie Loan Facility: Today’s News, Analyst Forecasts, and What to Watch Next

Applied Digital Corporation (APLD) Stock Jumps on New Macquarie Loan Facility: Today’s News, Analyst Forecasts, and What to Watch Next

Applied Digital shares rose about 7.4% to $23.63 midday December 18 after announcing a development loan facility with Macquarie Group. The $100 million facility, secured via subsidiary APLD DevCo LLC, will fund early-stage work on new data center projects. The company said it is in advanced talks with an investment-grade hyperscaler for multiple campuses. Trading volume was heavy following the financing news.
18 December 2025
·
Almonty Industries Stock (ALM, AII) on 18 December 2025: Sangdong Mine Hits “First Ore” Milestone, Funding Overhang Clears, and Analysts Re-Run the Models

Almonty Industries Stock (ALM, AII) on 18 December 2025: Sangdong Mine Hits “First Ore” Milestone, Funding Overhang Clears, and Analysts Re-Run the Models

Almonty Industries delivered the first truckload of ore to the run-of-mine pad at its Sangdong Tungsten Mine in South Korea, marking a shift from construction to mining operations. Shares on NASDAQ rose about 8.7% to $8.52 with heavy volume. The company positions Sangdong as a strategic supply source amid global efforts to reduce reliance on Chinese tungsten.
18 December 2025
···
Core Natural Resources (CNR) Stock Jumps on Leer South Restart: 2026 Outlook, Analyst Targets, and What to Watch

Core Natural Resources (CNR) Stock Jumps on Leer South Restart: 2026 Outlook, Analyst Targets, and What to Watch

Core Natural Resources shares jumped about 8% to $90 Thursday after the company announced the restart of longwall mining at its Leer South mine in West Virginia. Operations had been suspended since January due to combustion-related issues. The company also reported stable productivity at its West Elk mine in Colorado following a seam transition. Management expects Leer South to be fully ramped by early 2026.
18 December 2025
·
Rocket Lab Stock Jumps After Early U.S. Space Force Launch: RKLB News, Forecasts, and Fresh 2025 Valuation Debate (Dec. 18, 2025)

Rocket Lab Stock Jumps After Early U.S. Space Force Launch: RKLB News, Forecasts, and Fresh 2025 Valuation Debate (Dec. 18, 2025)

Rocket Lab launched the STP‑S30 mission for the U.S. Space Force five months ahead of schedule, deploying four DiskSat spacecraft from Virginia early Thursday. Shares rose in midday trading, reaching the mid‑$50s. The mission marked Rocket Lab’s 20th Electron launch in 2025 and its 78th overall. DiskSat, a NASA-backed tech demo, aims to test a new smallsat form factor.
18 December 2025
····
1 … 422 423 424 425 426 … 584
Go toTop